Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM

ClinicalTrials.gov ID: NCT02058147

Public ClinicalTrials.gov record NCT02058147. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 10:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, 30 Week, Active-controlled, Open-label, 3-treatment Arm, Parallel-group Multicenter Study Comparing the Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination to Insulin Glargine Alone and to Lixisenatide Alone on Top of Metformin in Patients With Type 2 Diabetes Mellitus (T2DM)

Study identification

NCT ID
NCT02058147
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
1,170 participants

Conditions and interventions

Interventions

  • Insulin glargine (HOE901) Drug
  • Insulin glargine/lixisenatide Fixed Ratio Combination Drug
  • Lixisenatide (AVE0010) Drug
  • Metformin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2014
Primary completion
May 31, 2015
Completion
May 31, 2015
Last update posted
May 8, 2017

2014 – 2015

United States locations

U.S. sites
118
U.S. states
36
U.S. cities
101
Facility City State ZIP Site status
Investigational Site Number 840027 Phoenix Arizona 85028
Investigational Site Number 840122 Phoenix Arizona 85032
Investigational Site Number 840062 Tempe Arizona 85282
Investigational Site Number 840023 Tempe Arizona
Investigational Site Number 840084 Little Rock Arkansas 72205
Investigational Site Number 840100 Anaheim California 92801
Investigational Site Number 840065 Bell Gardens California 90201
Investigational Site Number 840090 Chino California 91710
Investigational Site Number 840002 Chula Vista California 91911
Investigational Site Number 840013 Concord California 94520
Investigational Site Number 840053 Fresno California 93720
Investigational Site Number 840017 La Jolla California 92037
Investigational Site Number 840070 Lancaster California 93534
Investigational Site Number 840121 Long Beach California 90806
Investigational Site Number 840126 Los Angeles California 90017
Investigational Site Number 840044 Los Angeles California 90057
Investigational Site Number 840101 Mission Hills California 91345
Investigational Site Number 840086 Mission Viejo California 92691
Investigational Site Number 840120 Mission Viejo California 92691
Investigational Site Number 840005 Northridge California 91325
Investigational Site Number 840034 Palm Springs California 92262
Investigational Site Number 840074 Port Hueneme California 93041
Investigational Site Number 840068 San Ramon California 94583
Investigational Site Number 840067 Santa Ana California 92704
Investigational Site Number 840029 Tarzana California 91356
Investigational Site Number 840006 Temecula California 92591
Investigational Site Number 840078 West Hills California 91345
Investigational Site Number 840059 Aurora Colorado 80045
Investigational Site Number 840038 Denver Colorado 80246
Investigational Site Number 840104 Bradenton Florida 34208
Investigational Site Number 840098 Miami Florida 33156-7563
Investigational Site Number 840014 New Port Richey Florida 34652
Investigational Site Number 840047 Ocoee Florida 34761
Investigational Site Number 840056 Palm Harbor Florida 34684
Investigational Site Number 840089 Atlanta Georgia 30322
Investigational Site Number 840054 Lawrenceville Georgia 30046
Investigational Site Number 840119 Woodstock Georgia 30189
Investigational Site Number 840108 Idaho Falls Idaho 83404
Investigational Site Number 840075 Arlington Heights Illinois 60005
Investigational Site Number 840080 Chicago Illinois 60607
Investigational Site Number 840026 Chicago Illinois 60612
Investigational Site Number 840116 Chicago Illinois 60616
Investigational Site Number 840050 Springfield Illinois 62704
Investigational Site Number 840008 Avon Indiana 46123
Investigational Site Number 840015 Avon Indiana 46123
Investigational Site Number 840076 Avon Indiana 46123
Investigational Site Number 840082 Evansville Indiana 47713
Investigational Site Number 840031 Evansville Indiana 47714
Investigational Site Number 840060 Evansville Indiana 47714
Investigational Site Number 840048 Indianapolis Indiana 46202
Investigational Site Number 840085 Indianapolis Indiana 46260
Investigational Site Number 840012 Valparaiso Indiana
Investigational Site Number 840025 Waterloo Iowa 50702
Investigational Site Number 840022 Lexington Kentucky 40504
Investigational Site Number 840007 Louisville Kentucky 40213
Investigational Site Number 840081 New Orleans Louisiana 70112
Investigational Site Number 840097 Auburn Maine 04210
Investigational Site Number 840063 Rockville Maryland 20852
Investigational Site Number 840028 Bloomfield Hills Michigan
Investigational Site Number 840071 Chesterfield Michigan 48047
Investigational Site Number 840001 Dearborn Michigan 48124
Investigational Site Number 840091 Kalamazoo Michigan 49048
Investigational Site Number 840009 Minneapolis Minnesota 55416
Investigational Site Number 840024 Chesterfield Missouri 63017
Investigational Site Number 840057 Butte Montana 59701
Investigational Site Number 840042 Omaha Nebraska 68131
Investigational Site Number 840109 Henderson Nevada 89052
Investigational Site Number 840052 Las Vegas Nevada 89148
Investigational Site Number 840069 Nashua New Hampshire 03063
Investigational Site Number 840123 Morganville New Jersey 07751
Investigational Site Number 840011 Albuquerque New Mexico 87131
Investigational Site Number 840030 New Hyde Park New York 11042
Investigational Site Number 840096 Syracuse New York 13214-2016
Investigational Site Number 840039 Asheville North Carolina 28803
Investigational Site Number 840021 Hickory North Carolina 28601
Investigational Site Number 840046 Morehead City North Carolina 28557
Investigational Site Number 840072 Morganton North Carolina 28655
Investigational Site Number 840110 Salisbury North Carolina 28144
Investigational Site Number 840095 Wilmington North Carolina 28401
Investigational Site Number 840099 Winston-Salem North Carolina 27103
Investigational Site Number 840004 Columbus Ohio 43213
Investigational Site Number 840016 Maumee Ohio 43537
Investigational Site Number 840103 Eugene Oregon 97404
Investigational Site Number 840113 Portland Oregon 97201-3098
Investigational Site Number 840036 Pittsburgh Pennsylvania 15473
Investigational Site Number 840043 Tipton Pennsylvania 16684
Investigational Site Number 840058 Anderson South Carolina 29621
Investigational Site Number 840127 Charleston South Carolina 29407
Investigational Site Number 840049 Greer South Carolina 29651
Investigational Site Number 840114 Rapid City South Dakota 57701
Investigational Site Number 840112 Bristol Tennessee 37620
Investigational Site Number 840094 Knoxville Tennessee 37912
Investigational Site Number 840051 Austin Texas 78758
Investigational Site Number 840066 Corpus Christi Texas 78404
Investigational Site Number 840111 Dallas Texas 75208
Investigational Site Number 840020 Dallas Texas 75216
Investigational Site Number 840064 Dallas Texas 75230
Investigational Site Number 840003 Dallas Texas 75231
Investigational Site Number 840088 Edinburg Texas 78539
Investigational Site Number 840118 Fort Worth Texas 76132
Investigational Site Number 840055 Houston Texas 77004
Investigational Site Number 840087 Houston Texas 77030
Investigational Site Number 840079 Hurst Texas 76054
Investigational Site Number 840073 N Richland Hill Texas 76180
Investigational Site Number 840019 San Antonio Texas 78229
Investigational Site Number 840037 Draper Utah 84020
Investigational Site Number 840093 Ogden Utah 84405
Investigational Site Number 840061 Salt Lake City Utah 84102
Investigational Site Number 840041 Salt Lake City Utah 84107
Investigational Site Number 840040 Chesapeake Virginia 23321
Investigational Site Number 840045 Norfolk Virginia 23510
Investigational Site Number 840092 Norfolk Virginia 23510
Investigational Site Number 840125 Richmond Virginia 23219
Investigational Site Number 840115 Salem Virginia 24153
Investigational Site Number 840010 Weber City Virginia 24290
Investigational Site Number 840077 Federal Way Washington 98003
Investigational Site Number 840102 Renton Washington 98055
Investigational Site Number 840033 Milwaukee Wisconsin 53209-0996

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 155 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02058147, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 8, 2017 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02058147 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →